Piet Kramer

3.8k citations

19 papers · 3.1k indexed · 3 hit papers · h-index 15

Public Health, Environmental and Occupational Health top 0.5%
Reproductive Medicine top 0.2%
Molecular Biology top 10%
Genetics top 5%
Pediatrics, Perinatology and Child Health top 5%

Co-authors: Axel P. N. Themmen Bas Karels Alexandra L. L. Durlinger J. Anton Grootegoed J. Th. J. Uilenbroek Frank H. de Jong Jenny A. Visser Holly A. Ingraham
Topics: Reproductive Biology and Fertility (9 papers)Ovarian function and disorders (7 papers)Birth, Development, and Health (2 papers)
Cited by: Reproductive Medicine Public Health, Environmental and Occupational Health Agronomy and Crop Science
Journals: Journal of Neuroscience PLoS ONE Oncogene
Partner nations: Netherlands United States United Kingdom

In The Last Decade

Piet Kramer

19 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Control of Primordial Follicle Recruitment by Anti-Mullerian Hormone in the Mouse Ovary1

1999 782 citations Alexandra L. L. Durlinger, Piet Kramer et al. Endocrinology profile →
Anti-Mullerian Hormone Inhibits Initiation of Primordial Follicle Growth in the Mouse Ovary

2002 651 citations Alexandra L. L. Durlinger, Piet Kramer et al. Endocrinology profile →
Anti-Mullerian Hormone Attenuates the Effects of FSH on Follicle Development in the Mouse Ovary

2001 591 citations Alexandra L. L. Durlinger, Piet Kramer et al. Endocrinology profile →

Peers

Countries citing papers authored by Piet Kramer

Since Specialization

Citations

This map shows the geographic impact of Piet Kramer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Piet Kramer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Piet Kramer more than expected).

Fields of papers citing papers by Piet Kramer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Piet Kramer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Piet Kramer. The network helps show where Piet Kramer may publish in the future.

Co-authorship network of co-authors of Piet Kramer

This figure shows the co-authorship network connecting the top 25 collaborators of Piet Kramer. A scholar is included among the top collaborators of Piet Kramer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Piet Kramer. Piet Kramer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Loss of Anti-Müllerian Hormone Signaling in Mice Affects Trabecular Bone Mass in a Sex- and Age-Dependent Manner 2022 ·Endocrinology ·(unknown),Marijke Koedam,Anke McLuskey,Piet Kramer,Najiba Lahlou,Bram C. J. van der Eerden,Jenny A. Visser	6
2	The Tyrosine Kinase Inhibitor Sunitinib Affects Ovulation but Not Ovarian Reserve in Mouse: A Preclinical Study 2016 ·PLoS ONE ·Valérie Bernard,Justine Bouilly,Piet Kramer,Nadège Carré,Martin Schlumberger,Jenny A. Visser,Jacques Young,Nadine Binart	16
3	Plasma acylated and plasma unacylated ghrelin: useful new biomarkers in patients with neuroendocrine tumors? 2016 ·Endocrine Connections ·(unknown),Aart Jan van der Lely,Martin Huisman,Piet Kramer,Richard A. Feelders,Patric J. D. Delhanty,Wouter W. de Herder	4
4	Haloferax volcanii, a Prokaryotic Species that Does Not Use the Shine Dalgarno Mechanism for Translation Initiation at 5′-UTRs 2014 ·PLoS ONE ·Piet Kramer,(unknown),Friedhelm Pfeiffer,Jörg Soppa	24
5	Analysis of the vascular responses in a murine model of polycystic ovary syndrome 2013 ·Journal of Endocrinology ·(unknown),(unknown),René de Vries,(unknown),Ingrid M. Garrelds,Piet Kramer,A.H. Jan Danser,Carlos M. Villalón,Jenny A. Visser,Antoinette MaassenVanDenBrink	12
6	Reproductive and Metabolic Phenotype of a Mouse Model of PCOS 2012 ·Endocrinology ·(unknown),Piet Kramer,Anke McLuskey,Bas Karels,Axel P. N. Themmen,Jenny A. Visser	145
7	Fancf‐deficient mice are prone to develop ovarian tumours 2011 ·The Journal of Pathology ·Sietske T. Bakker,Henri J. van de Vrugt,Jenny A. Visser,(unknown),(unknown),(unknown),Marieke van de Ven,Anneke B. Oostra,(unknown),Piet Kramer,Fré Arwert,Martin van der Valk,Johan P. de Winter,Hein te Riele	29
8	Increased Oocyte Degeneration and Follicular Atresia during the Estrous Cycle in Anti-Müllerian Hormone Null Mice 2007 ·TU/e Research Portal (Eindhoven University of Technology) ·Jenny A. Visser,Alexandra L. L. Durlinger,(unknown),Edwin R. van den Heuvel,Ursula M. Rose,Piet Kramer,Frank H. de Jong,Axel P. N. Themmen	1
9	Estradiol Improves Cerebellar Memory Formation by Activating Estrogen Receptor β 2007 ·Journal of Neuroscience ·Corina Andreescu,Bogdan Milojkovic,Elize D. Haasdijk,Piet Kramer,Frank H. de Jong,Andrée Krust,Chris I. De Zeeuw,Marcel T. G. de Jeu	69
10	Intravenous Glucose Administration in Fasting Rats Has Differential Effects on Acylated and Unacylated Ghrelin in the Portal and Systemic Circulation: A Comparison between Portal and Peripheral Concentrations in Anesthetized Rats 2007 ·Endocrinology ·Carlotta Gauna,André G. Uitterlinden,Piet Kramer,Rosalie M. Kiewiet,J. A. M. J. L. Janssen,Patric J. D. Delhanty,Maarten O. van Aken,Ezio Ghigo,Leo J. Hofland,Axel P. N. Themmen,Aart Jan van der Lely	16
11	Increased Oocyte Degeneration and Follicular Atresia during the Estrous Cycle in Anti-Mullerian Hormone Null Mice 2007 ·Endocrinology ·Jenny A. Visser,Alexandra L. L. Durlinger,(unknown),Edwin R. van den Heuvel,Ursula M. Rose,Piet Kramer,Frank H. de Jong,Axel P. N. Themmen	137
12	Serum Anti-Müllerian Hormone Levels Reflect the Size of the Primordial Follicle Pool in Mice 2006 ·Endocrinology ·Marlies E. Kevenaar,(unknown),Piet Kramer,(unknown),Frank H. de Jong,Nigel P. Groome,Axel P. N. Themmen,Jenny A. Visser	320
13	Anti-Mullerian Hormone Inhibits Initiation of Primordial Follicle Growth in the Mouse Ovarybreakdown → 2002 ·Endocrinology ·Alexandra L. L. Durlinger,(unknown),Piet Kramer,Bas Karels,Holly A. Ingraham,Mark W. Nachtigal,J. Th. J. Uilenbroek,J. Anton Grootegoed,Axel P. N. Themmen	651
14	The Serine/Threonine Transmembrane Receptor ALK2 Mediates Mullerian Inhibiting Substance Signaling 2001 ·Molecular Endocrinology ·Jenny A. Visser,Robert Olaso,Miriam Verhoef‐Post,Piet Kramer,Axel P. N. Themmen,Holly A. Ingraham	130
15	Anti-Mullerian Hormone Attenuates the Effects of FSH on Follicle Development in the Mouse Ovarybreakdown → 2001 ·Endocrinology ·Alexandra L. L. Durlinger,(unknown),Piet Kramer,Bas Karels,T. Rajendra Kumar,Martin M. Matzuk,Ursula M. Rose,Frank H. de Jong,J. Th. J. Uilenbroek,J. Anton Grootegoed,Axel P. N. Themmen	591
16	Apoptotic and proliferative changes during induced atresia of pre-ovulatory follicles in the rat 2000 ·Human Reproduction ·Alexandra L. L. Durlinger,Piet Kramer,Bas Karels,J. Anton Grootegoed,J. Th. J. Uilenbroek,Axel P. N. Themmen	30
17	Control of Primordial Follicle Recruitment by Anti-Mullerian Hormone in the Mouse Ovary1breakdown → 1999 ·Endocrinology ·Alexandra L. L. Durlinger,Piet Kramer,Bas Karels,Frank H. de Jong,J. Th. J. Uilenbroek,J. Anton Grootegoed,Axel P. N. Themmen	782
18	Effect of Prenatal Exposure to Diethylstilbestrol on Mullerian Duct Development in Fetal Male Mice*This work was supported by The Netherlands Organization for Scientific Research (NWO) through GB-MW (Medical Sciences). 1998 ·Endocrinology* ·Jenny A. Visser,Anke McLuskey,Miriam Verhoef‐Post,Piet Kramer,J. Anton Grootegoed,Axel P. N. Themmen	45
19	Human growth-differentiation factor 3 (hGDF3): developmental regulation in human teratocarcinoma cell lines and expression in primary testicular germ cell tumours 1998 ·Oncogene ·Andrea Caricasole,Ron HN van Schaik,Laura Zeinstra,(unknown),(unknown),(unknown),Leendert H. J. Looijenga,J. Wolter Oosterhuis,Martín F. Pera,Andrew Ward,Diederik de Bruijn,Piet Kramer,Frank H. de Jong,(unknown)	51

About Piet Kramer

Piet Kramer is a scholar working on Reproductive Medicine, Public Health, Environmental and Occupational Health and Endocrine and Autonomic Systems, having authored 19 papers that have together received 3.1k indexed citations. Recurring topics across this work include Reproductive Biology and Fertility (9 papers), Ovarian function and disorders (7 papers) and Birth, Development, and Health (2 papers). The work is most often cited by research in Reproductive Medicine (2.1k citations), Public Health, Environmental and Occupational Health (2.3k citations) and Agronomy and Crop Science (255 citations). Piet Kramer has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include Axel P. N. Themmen, Bas Karels, Alexandra L. L. Durlinger, J. Anton Grootegoed, J. Th. J. Uilenbroek, Frank H. de Jong, Jenny A. Visser, Holly A. Ingraham, Mark W. Nachtigal and Ursula M. Rose. Their work appears in journals such as Journal of Neuroscience, PLoS ONE and Oncogene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact